Cingulate (CING) EVP receives 3,422-share stock option award

Rhea-AI Filing Summary

Cingulate Inc. reported that EVP and CSO Raul R. Silva received a grant of stock options covering 3,422 shares of common stock. The options have an exercise price of $6.21 per share, were granted at no purchase cost, and expire on March 31, 2036. The award was made pursuant to Dr. Silva's Employment Agreement, as amended, and reflects equity-based compensation rather than an open-market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Silva Raul R.

Role EVP and CSO

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to Buy)	3,422	$0.00	--

Holdings After Transaction: Stock Option (right to Buy) — 3.422 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Option grant size: 3,422 options Underlying shares: 3,422 shares Exercise price: $6.21 per share +3 more

6 metrics

Option grant size 3,422 options Stock Option (right to Buy) granted to Raul R. Silva

Underlying shares 3,422 shares Common Stock underlying the option award

Exercise price $6.21 per share Option exercise price for Cingulate common stock

Expiration date March 31, 2036 Option expiration for Raul R. Silva’s grant

Grant date March 31, 2026 Transaction date of the stock option award

Shares after transaction (derivative) 3.4220 Total derivative shares following transaction, as reported

Key Terms

Stock Option (right to Buy), Grant, award, or other acquisition, underlying security, Employment Agreement

4 terms

Stock Option (right to Buy) financial

"security_title: "Stock Option (right to Buy)""

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

underlying security financial

"underlying_security_title: "Common Stock""

Employment Agreement financial

"The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Silva Raul R.

(Last) (First) (Middle)

1901 W. 47TH PLACE

(Street)

KANSAS CITY KANSAS 66205

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cingulate Inc. [ CING ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CSO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to Buy)	$6.21	03/31/2026(1)		A		3,422		03/31/2026	03/31/2036	Common Stock	3,422	$0	3.422	D

Explanation of Responses:

1. The option was granted pursuant to the terms of Dr. Silva's Employment Agreement, as amended.

	/s/ Raul Silva	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Cingulate (CING) report for Raul R. Silva?

Cingulate reported that EVP and CSO Raul R. Silva received a stock option grant for 3,422 shares. The derivative award gives him the right to buy common stock at a fixed exercise price as part of his compensation package.

How many Cingulate (CING) shares are covered by Raul R. Silva’s new options?

The stock option grant to Raul R. Silva covers 3,422 shares of Cingulate common stock. These options provide potential future ownership if exercised, aligning part of his compensation with the company’s share performance over time.

What is the exercise price of Raul R. Silva’s Cingulate (CING) stock options?

The stock options granted to Raul R. Silva have an exercise price of $6.21 per share. This means he can purchase Cingulate common stock at $6.21 per share upon exercising the options, regardless of the future market trading price.

When do Raul R. Silva’s Cingulate (CING) stock options expire?

Raul R. Silva’s stock options expire on March 31, 2036. After that expiration date, any unexercised options will lapse and can no longer be used to purchase Cingulate common shares at the stated exercise price.

Did Raul R. Silva buy or sell Cingulate (CING) shares in this Form 4?

No open-market buy or sell occurred; instead, Raul R. Silva received a grant of stock options. The Form 4 classifies this as a “Grant, award, or other acquisition,” reflecting compensation rather than a discretionary share trade.

How were Raul R. Silva’s new Cingulate (CING) options authorized?

The filing notes that the option was granted pursuant to the terms of Dr. Silva’s Employment Agreement, as amended. This ties the equity award to his existing contractual compensation arrangements with Cingulate rather than a separate negotiated transaction.